Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The investigators intend to study whether the use of the pain medication etoricoxib (Arcoxia)
taken just before the Ramadan fast will prevent or lessen headache that some people get while
fasting. The investigators hypothesize that etoricoxib will reduce the number of people
getting headache, more than placebo. The investigators will do this by giving participants in
the study either real medication or placebo (sugar pill) and comparing the results. The
investigators will study this over two weeks. The first week one group will get the medicine
and the other the placebo. The second the groups will switch. Neither the subjects nor the
investigators will know who is in which group.